No. 17

Maternal overweight as risk factor for childhood leukemia in daughters

Bone marrow smear (large magnification) from a patient with acute lymphoblastic leukemia.

The weight of expectant mothers could play a role in the development of acute lymphoblastic leukemia (ALL) in daughters – but not in sons. This has been shown by researchers at the German Cancer Research Center (DKFZ).

Acute lymphoblastic leukemia is rare overall, but accounts for about a quarter of childhood cancers. To identify possible risk factors, a team led by Mahdi Fallah, DKFZ, together with colleagues from Lund University, analyzed data from almost 3 million births in Sweden over a period of 35 years. The data was taken from the Swedish nationwide family cancer registry.

During the study period, a total of 1,388 children in Sweden developed ALL. The results show that girls whose mothers were overweight or obese (BMI 25 and above) at the beginning of pregnancy had a 40 percent increased risk of developing ALL.

“Our results were also surprising to us,” says Mahdi Fallah, lead scientist of the study. ”They suggest that maternal obesity could be an overlooked risk factor for childhood leukemia – and that it is gender-specific.”

The researchers suspect that hormonal influences, particularly elevated estrogen levels during pregnancy, could play a role. Estrogens have been shown to affect gene expression and could increase the risk of leukemia in female offspring.

Encouragingly, the study showed no association between weight gain during pregnancy and ALL risk, which is a relief for expectant mothers concerned about their pregnancy weight gain.

The scientists are now planning further investigations to better understand the biological mechanisms behind this surprising sex-specific phenomenon. In the long term, the findings may lead to new prevention strategies. “Pregnancy is a crucial phase for a child's health,” emphasizes Fallah. “Our results underscore the importance of educating expectant mothers about healthy lifestyle habits early on – not only for their own well-being, but also for that of their children.”

 

Jiaye Liu, Elham Kharazmi, Qunfeng Liang, Yafei Chen, Jan Sundquist, Kristina Sundquist and Mahdi Fallah: Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring

Leukemia 2025, DOI: https://doi.org/10.1038/s41375-025-02517-6

Get in touch with us

Employee image
Press Contact

About DKFZ

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

Form

Form data is loaded ...